January 20, 2026 17:31 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics,…
January 20, 2026 17:20 ET | Source: Tempest Therapeutics BRISBANE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc.…
Press Release Nicox Announces Conference Attendance in H1 2026 and Upcoming Scientific Data PresentationsJanuary 20, 2026 – release at 7:30…
Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and…
NEW YORK, NY, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not…
Sales Highlights (unaudited): Global H1 sales AUD$4.2 million up 5% on prior comparative period (pcp)Q2 sales AUD$2.2 million up 11%…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…
January 19, 2026 03:00 ET | Source: Concept Life Sciences CHAPEL-EN-LE-FRITH, United Kingdom, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Concept…
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.…
January 16, 2026 16:05 ET | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”…